Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF), a medical cannabis cultivation and distribution company out of New Brunswick, Canada has announced its Q3 sales for 2018. Within the three month period the company was able to produce $3.7 million dollars in sales. This total surpasses what Organigram was capable of selling in the entire fiscal year of 2017.
Organigram has made a number of strategic moves during this period. In May, Organigram received its “License for Controlled Drugs and Substances” from Health Canada and its “Permit to Export Cannabis” license. This lead to the company’s first international export of medicinal cannabis to Australia in July.
Within the third quarter the company recorded the sale of 303,428 grams of dried cannabis flower, 768,400 milliliters of cannabis oil, and had accomplished rising its registered medical patient list to a company best of 15,316.
Organigram’s assets at the end of Q3 is as follows:
- $156 million in cash and short-term investments (up from $34 million at the August 31, 2017 year-end);
- $26.9 million in combined biological assets and inventories (up from $5.4 million at year-end);
- $83 million in property, plant and equipment (up from $45 million at year-end);
- $9 million in current liabilities (up from $6 million at year-end);
- $98 million in long-term debt and convertible debentures (up from $3 million at year-end)
You may be interested
Featured CCT Interview with CEO of Eden Labs AC BraddockEditor - August 20, 2018
Eden Labs LLC. has been developing and providing plant based extraction equipment out of Seattle, Washington for some of the largest and most respected companies involved in…
VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital PartnersEditor - August 17, 2018
Partnership to Focus on Growth in Horticultural and Cannabis Industries VividGro, LLC, a portfolio company of private equity firm Pegasus Capital Advisors (Pegasus), today announced it has…
Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 MillionEditor - August 15, 2018
Harborside, a California based cannabis dispensary brand with multiple locations, is planning the reverse takeover of Canadian public company Lineage Grow Company Ltd. (CSE: BUDD). Lineage is…